Buyouts
MBK to buy control of Korea e-commerce solutions provider
MBK Partners has agreed to buy a controlling stake in KoreaCenter, a Korea-based e-commerce services provider, for KRW 491.7bn (USD 429.8m) across several equity and debt transactions.
PE consortium cuts 51job take-private offer by 28%
A private equity consortium pursuing a take-private of US-listed Chinese online recruitment platform 51job has cut its offer price by 28%, citing deteriorating market conditions, regulatory tightening in China, and the continuing impact of COVID-19.
India sports: In it to win it
Private equity interest in the commercialisation of sport globally is filtering through to India, with a couple of high-profile cricket deals. What other franchises and rights owners could be up for grabs?
FountainVest buys China QSR restaurant operator from EQT
FountainVest Partners has acquired China F&B Group (CFB), one of the master franchise operators for Papa John’s and Dairy Queen in mainland China, from EQT for an undisclosed sum.
Japan's ACA buys Belgian football club
Japanese fund manager ACA Investments has created a football-focused unit under its Singapore-based subsidiary and acquired a club that competes in the second tier of the Belgian league.
PE consortium backs New Zealand fertility business
Pioneer Capital, New Zealand Superannuation Fund, and Comprador Holdings have together acquired a 70% stake in Fertility Associates, a New Zealand-based fertility treatment provider.
KKR to buy Japan SME software provider from Orix
KKR has agreed to buy Yayoi, a Japan-based software developer that serves small and medium-sized enterprises (SMEs) from Orix Corporation.
Advent acquires China's largest medical capsule maker
Advent International has acquired a majority stake in Guangsheng Medicinal Capsule (GS Capsule), the largest medical capsule maker in China, for an undisclosed sum.
BGH makes $432m bid for Australia's Virtus Health
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
Endeavor United to buy chemicals unit from Japan's Bridgestone
Endeavour United, a Japanese private equity firm established by the team behind turnaround investor Phoenix Capital, has agreed to buy Bridgestone Corporation’s chemical products solutions business for an undisclosed sum.
Blue Owl buys Asia-based placement agent
US alternative asset manager Blue Owl Capital has acquired Hong Kong placement agent Ascentium with a view to establishing a physical presence in the territory and pursuing a broader regional expansion.
Singapore's Aura acquires Australia vaccination player
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
CVC backs take-private of Hong Kong-listed Razer
CVC Capital Partners is supporting a proposed founder-led privatization of Hong Kong-listed gaming hardware and software provider Razer that values the business at HK$24.7 billion ($3.17 billion).
Wise Road buys semiconductor assets from Taiwan's ASE
Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to buy a package of assets from Taiwan-listed semiconductor business ASE Technology Holding for $1.46 billion.
Portfolio: Dymon Asia and AMES
For all the hubbub about digital businesses taking flight during the pandemic, few categories saw as much upside as traditional medical waste disposal. Dymon Asia Private Equity is enjoying the ride
Deal focus: Permira passes Tricor baton to Baring
Permira helped Tricor Group consolidate its position in Asian corporate services and upgrade its product offering. Under Baring Private Equity Asia’s ownership, the CEO wants to build a $10 billion company
Australia deal-by-deal player Alceon sees investment uptick
Australia-based deal-by-deal investor Alceon Private Equity expects to complete four investments this year, having expanded its scope from consumer and retail to include healthcare, childcare, and IT services.
PE investors wary of inflation in 2022 - AVCJ Forum
Inflation is top of mind for Asia-focused private equity investors as they assess the various uncertainties facing the industry in 2022, the AVCJ Private Equity & Venture Forum heard.
Deal focus: Orchestra delivers pizza to Seoul
Banolim has become Korea’s fourth-largest pizza delivery business largely on the back of savvy marketing and expansion in lower-tier cities. Orchestra Private Equity is supporting a rollout in Seoul
Deal focus: Icon retains its private equity appeal
EQT’s $1.67 billion acquisition of Icon Group underscores the recent trend in large-cap buyouts, as well as the long-term growth potential for cancer care specialists in Australia and the wider Asian region
Key takeaways: Apollo Global Management's Marc Rowan
High valuations, pursuing complexity, and eradicating write-offs were on the agenda when Marc Rowan, co-founder and CEO of Apollo Global Management, spoke at the AVCJ Forum. Here are some highlights
EQT buys Australia cancer care business from PE consortium
Goldman Sachs Asset Management, QIC, and Pagoda Investment – a China-focused GP set up by a former QIC executive – have agreed to sell Australia cancer care provider Icon Group to EQT for a reported valuation of A$2.3 billion ($1.67 billion).